At the Center for Neurology and Spine, we are committed to raising awareness about dementia, a condition projected to affect millions of Americans in the coming decades. Recent studies highlight that dementia cases in the U.S. could rise to nearly 1 million annually by 2060, making it more important than ever to understand this condition and take proactive steps to reduce risk.
The new study (Lifetime risk and projected burden of dementia | Nature Medicine) relies on information gathered from the ongoing Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS), which, since 1987, has closely tracked the vascular health and cognitive function of nearly 16,000 participants as they age. ARIC-NCS is also, the researchers say, the longest-followed cohort of African-Americans for cognition and heart health.
Publishing in the journal Nature Medicine online Jan. 13, the study concludes that from 1987 until 2020, there were 3,252 study participants who were documented as having developed dementia.
This translates to an overall lifetime risk for dementia among middle-aged Americans of 42%, which is an average of the 35% risk in men and the 48% risk in women. The excess risk in women was largely due to their lower death rates.
The new results also showed a higher risk among Black adults and in those who carried a variant of the APOE4 gene (between 45% and 60%), which codes for a protein that carries cholesterol and other lipids in the bloodstream.
Having a certain version of APOE4 is thought to be the single biggest genetic risk factor in developing late-onset Alzheimer’s disease.
According to the study, dementia cases are expected to rise dramatically due to an aging population. The research emphasizes the importance of public health strategies to prepare for this surge and improve quality of life for those affected.
Dementia is a group of cognitive disorders that impact memory, thinking, and the ability to perform daily tasks. Alzheimer’s disease is the most common form, but other types include:
While there is no cure, medications and therapies aim to slow progression and manage symptoms:
Ongoing clinical trials are exploring innovative ways to combat dementia:
While some risk factors like age and genetics are unavoidable, you can take steps to lower your risk:
Arizona is uniquely positioned to support advancements in dementia research, with a growing population of older adults and access to cutting-edge clinical trials. By participating in research and adopting preventive measures, residents can contribute to groundbreaking discoveries and live healthier lives.
At the Center for Neurology and Spine, we encourage patients and families to stay informed and explore opportunities to participate in clinical trials. Together, we can advance understanding and develop more effective treatments for dementia.
Visit CenterForNeurologyAndSpine.com for more information and resources.
#DementiaAwareness #AlzheimersResearch #NeurologyArizona #BrainHealth #CognitiveDecline #ClinicalTrials #HealthyAging
Take charge of your brain health today—because every step matters!